CG
DNLI icon

Cutler Group’s Denali Therapeutics DNLI Stock Holding History

Cutler Group’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$8K Hold
400
– – ﹤0.01% 1367
2023
Q4 		$8K Buy
+400
New +$7.92K ﹤0.01% 2510
2023
Q2 		– Sell
-600
Closed -$13K – 3766
2023
Q1 		$13K Sell
600
-1,650
-73% -$45.4K ﹤0.01% 2146
2022
Q4 		$62K Buy
2,250
+1,450
+181% +$43.1K 0.01% 1436
2022
Q3 		$24K Buy
800
+120
+18% +$3.9K ﹤0.01% 2466
2022
Q2 		$20K Sell
680
-620
-48% -$16.2K ﹤0.01% 2667
2022
Q1 		$41K Sell
1,300
-400
-24% -$13.8K ﹤0.01% 2418
2021
Q4 		$75K Buy
1,700
+540
+47% +$25.6K 0.01% 2074
2021
Q3 		$58K Buy
+1,160
New +$65.4K ﹤0.01% 2386
2021
Q2 		– Sell
-600
Closed -$37.1K – 5884
2021
Q1 		$34K Buy
+600
New +$40.2K ﹤0.01% 2727
2020
Q4 		– Hold
0
– – – 5017
2020
Q3 		– Sell
-1,440
Closed -$43.4K – 4865
2020
Q2 		$34K Sell
1,440
-60
-4% -$1.41K ﹤0.01% 2019
2020
Q1 		$26K Buy
1,500
+1,000
+200% +$20.9K ﹤0.01% 2127
2019
Q4 		$8K Buy
500
+400
+400% +$6.66K ﹤0.01% 2744
2019
Q3 		$1K Hold
100
– – ﹤0.01% 3691
2019
Q2 		$2K Buy
+100
New +$2.24K ﹤0.01% 3533
2019
Q1 		– Sell
-100
Closed -$2K – 4263
2018
Q4 		$2K Buy
+100
New +$1.81K ﹤0.01% 3335

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return